Healthcare entities’ reporting impacts of COVID-19 aid
Hot Topic | April 2020
Implications of government aid on the accounting and financial reporting of healthcare entities.
Share
Healthcare entities are receiving COVID-19 government assistance from a number of different sources. KPMG addresses the accounting for this aid.
Applicability
- All non-governmental healthcare entities
Relevant dates
- CARES Act was signed into law on March 27, 2020
- $30 billion of provider relief funding was disbursed in two installments on April 10 and April 17, 2020
- HHS announced plans to disburse additional provider relief funding on April 22, 2020
- Effective immediately
Key impacts:
- Payments made to a healthcare entity for services provided to its Medicare patients represent transaction price for the services provided and are accounted for under ASC 606.
- For payments made from the $50 billion of general allocations of provider relief funding:
- Not-for-profit healthcare entities will account for funds received as a conditional contribution under ASC 958-605.
- For-profit healthcare entities will consider their previous accounting policies and analogous accounting guidance to account for funds received.
- The funds received from the CARES Act provider relief funding is considered a Type II nonrecognized subsequent event for reporting periods before its disbursement; this is because the Act required subsequent action by the HHS Secretary.
Report contents
- Medicare payments
- Government assistance for COVID-19 response
- Subsequent events
Download the document:
Explore more
Resource
Legislative relief for COVID-19
Updated: Financial reporting considerations of the combined provisions of the American Rescue Plan Act and other relief.
Resource
Recognizing insurance claims related to COVID-19
Guidance on when to recognize insurance recoveries, as well as measurement, presentation and disclosure requirements.
Resource
Broad disclosure impacts of COVID-19
Updated: Subsequent events, going concern, unusual items, risks and uncertainties evaluation and disclosures.
Meet our team
Joseph Bukzin
Partner, Audit, KPMG US
Meredith Canady
Partner, Dept. of Professional Practice, KPMG US
Kayla Futch
Managing Director, Dept. of Professional Practice, KPMG US
Jody Love
Office Managing Partner, Baltimore, Partner, Audit, KPMG US
Joseph Bukzin
Partner, Audit, KPMG US
Meredith Canady
Partner, Dept. of Professional Practice, KPMG US
Kayla Futch
Managing Director, Dept. of Professional Practice, KPMG US
Jody Love
Office Managing Partner, Baltimore, Partner, Audit, KPMG US